Immune Checkpoint Inhibitor PD-1 Antibody Combined With Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX) Regimen vs. PD-1 Antibody Combined With Oxaliplatin, Tigio (SOX) Regimen During Perioperative Period A Randomized Controlled Phase II Clinical Study for the Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Latest Information Update: 06 Jul 2023
At a glance
- Drugs Toripalimab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin; Tegafur
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
Most Recent Events
- 06 Jul 2023 New trial record
- 06 Jun 2023 Results (n=54) presented at the 59th Annual Meeting of the American Society of Clinical Oncology.